Effects of 2 Weeks Treatment With Dapagliflozin in Subjects With an Impaired Glucose Homeostasis on Nocturnal Substrate Oxidation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
To investigate if dapagliflozin improves nocturnal substrate oxidation expressed as respiration quotient (RQ) during the sleeping period in comparison with placebo after 2‐weeks double blind treatment in subjects with a disrupted glucose homeostasis.
Epistemonikos ID: e1ebeaf53f3d66e08bd22765a8d57971634fbd8c
First added on: May 21, 2024